La Jolla Pharmaceutical Company (LJPC)-Financial and Strategic SWOT Analysis Review
August 2017
40
About the Report
About the Report
La Jolla Pharmaceutical Company (LJPC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
La Jolla Pharmaceutical Company (La Jolla) is a biopharmaceutical company, which discovers, develops and markets pharmaceutical products for life threatening diseases. The company's product pipeline includes LJPC-501, a formulation of angiotensin II is being developed for the treatment of catecholamine-resistant hypotension; LJPC-401, formulation of synthetic human hepcidin for the treatment of iron overload such as hereditary hemochromatosis, myelodysplastic syndrome and sickle cell disease; and LJPC-30S, a gentamicin derivative program is being developed for the treatment of serious bacterial infections and rare genetic disorders including cystic fibrosis and Duchenne muscular dystrophy. La Jolla is headquartered in San Diego, California, the US.
La Jolla Pharmaceutical Company Key Recent Developments
Jul 27,2017: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate Progress
Apr 27,2017: La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate Progress
Feb 23,2017: La Jolla Pharmaceutical Company Announces Fourth Quarter and Full Year 2016 Financial Results and Corporate Progress
Nov 03,2016: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2016 and Recent Corporate Progress
Aug 08,2016: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2016
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
La Jolla Pharmaceutical Company, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1-About the Company 6
La Jolla Pharmaceutical Company-Key Facts 6
La Jolla Pharmaceutical Company-Key Employees 7
La Jolla Pharmaceutical Company-Key Employee Biographies 8
La Jolla Pharmaceutical Company-Major Products and Services 9
La Jolla Pharmaceutical Company-History 10
La Jolla Pharmaceutical Company-Company Statement 11
La Jolla Pharmaceutical Company-Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2-Company Analysis 14
La Jolla Pharmaceutical Company-Business Description 14
La Jolla Pharmaceutical Company-SWOT Analysis 15
SWOT Analysis-Overview 15
La Jolla Pharmaceutical Company-Strengths 15
La Jolla Pharmaceutical Company-Weaknesses 16
La Jolla Pharmaceutical Company-Opportunities 17
La Jolla Pharmaceutical Company-Threats 18
La Jolla Pharmaceutical Company-Key Competitors 19
Section 3-Company Financial Ratios 20
Financial Ratios-Capital Market Ratios 20
Financial Ratios-Annual Ratios 21
Performance Chart 23
Financial Performance 23
Financial Ratios-Interim Ratios 24
Financial Ratios-Ratio Charts 25
Section 4-Company's Lifesciences Financial Deals and Alliances 26
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
La Jolla Pharmaceutical Company, Recent Deals Summary 28
Section 5-Company's Recent Developments 29
Jul 27, 2017: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2017 and Recent Corporate Progress 29
Apr 27, 2017: La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate Progress 30
Feb 23, 2017: La Jolla Pharmaceutical Company Announces Fourth Quarter and Full Year 2016 Financial Results and Corporate Progress 31
Nov 03, 2016: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2016 and Recent Corporate Progress 32
Aug 08, 2016: La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2016 33
May 06, 2016: La Jolla Pharmaceutical Company Announces First Quarter 2016 Financial Results and Recent Corporate Progress 34
Feb 25, 2016: La Jolla Pharmaceutical Company Announces Fourth Quarter and Full Year 2015 Financial Results and Highlights Corporate Progress 35
Section 6-Appendix 36
Methodology 36
Ratio Definitions 36
About GlobalData 40
Contact Us 40
Disclaimer 40
List of Figure
List of Figures
La Jolla Pharmaceutical Company, Performance Chart (2012-2016) 23
La Jolla Pharmaceutical Company, Ratio Charts 25
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 27
List of Table
List of Tables
La Jolla Pharmaceutical Company, Key Facts 6
La Jolla Pharmaceutical Company, Key Employees 7
La Jolla Pharmaceutical Company, Key Employee Biographies 8
La Jolla Pharmaceutical Company, Major Products and Services 9
La Jolla Pharmaceutical Company, History 10
La Jolla Pharmaceutical Company, Subsidiaries 13
La Jolla Pharmaceutical Company, Key Competitors 19
La Jolla Pharmaceutical Company, Ratios based on current share price 20
La Jolla Pharmaceutical Company, Annual Ratios 21
La Jolla Pharmaceutical Company, Annual Ratios (Cont...1) 22
La Jolla Pharmaceutical Company, Interim Ratios 24
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
La Jolla Pharmaceutical Company, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
La Jolla Pharmaceutical Company, Recent Deals Summary 28
Currency Codes 36
Capital Market Ratios 36
Equity Ratios 37
Profitability Ratios 37
Cost Ratios 38
Liquidity Ratios 38
Leverage Ratios 39
Efficiency Ratios 39
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.